These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12380350)

  • 1. [The first monoclonal antibody against IgE. The end of allergies? (interview by Dr. Judith Neumaier)].
    Bergmann KC
    MMW Fortschr Med; 2002 Sep; 144(35-36):12. PubMed ID: 12380350
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction: anti-IgE.
    Bochner B; Saini S
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):1-2. PubMed ID: 16222079
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S; Richter D; Cepelak I; Benko B
    Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-IGE therapy in asthma].
    Mehiri Ben Rhouma N; Béji M; Louzir B; Daghfous J
    Tunis Med; 2002 Oct; 80(10):575-80. PubMed ID: 12632749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allergic rhinitis and bronchial asthma. Stepwise plans for the treatment].
    Bischoff A
    MMW Fortschr Med; 2009 May; 151(19):18-9. PubMed ID: 19827437
    [No Abstract]   [Full Text] [Related]  

  • 10. [Seasonal variations of serum-IgE and potential impact on dose-calculation of omalizumab (rhuMab-E25, anti-IgE)].
    Beeh KM; Beier J; Buhl R
    Pneumologie; 2004 Aug; 58(8):546-51. PubMed ID: 15293167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-IgE therapy].
    Chazan R
    Pol Merkur Lekarski; 2003 Jun; 14(84):617-20. PubMed ID: 14524285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma].
    Targowski T; From S
    Pol Merkur Lekarski; 2003 Jan; 14(79):65-8. PubMed ID: 12712834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD-sens and clinical changes during withdrawal of Xolair after 6 years of treatment.
    Nopp A; Johansson SG; Ankerst J; Palmqvist M; Oman H
    Allergy; 2007 Oct; 62(10):1175-81. PubMed ID: 17845588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On asthma and allergic reactions. Omalizumab: from IgE to anti-IgE].
    Ladetzki-Baehs K; Dirsch VM; Vollmar AM
    Pharm Unserer Zeit; 2004; 33(2):116-22. PubMed ID: 15083621
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
    D'Amato G
    Expert Opin Biol Ther; 2003 Apr; 3(2):371-6. PubMed ID: 12662149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW; Massanari M; Kianifard F; Geba GP
    Curr Med Res Opin; 2007 Oct; 23(10):2379-86. PubMed ID: 17711616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of allergic asthma with monoclonal anti-IgE antibody.
    Salvi SS; Babu KS
    N Engl J Med; 2000 Apr; 342(17):1292-3. PubMed ID: 10787335
    [No Abstract]   [Full Text] [Related]  

  • 19. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
    Liebhaber M; Dyer Z
    J Asthma; 2007 Apr; 44(3):195-6. PubMed ID: 17454337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.